Inventor · disambiguated record
Peter B. Kirk
Also filed as: KIRK PETER · KIRK PETER B · KIRK PETER BENEDICT
6 granted patents·12 pending applications·5 citations·filing 2002–2025
72Inventor score
Top patents by PatentIndex Score
18 records- 0175US8680019B2Universal fibronectin Type III binding-domain librariesCAPPUCCILLI GUIDO·Filed 2009·Granted Mar 25, 2014·2 cites·18 claims
- 0274US8470966B2Universal fibronectin type III binding-domain librariesCAPPUCCILLI GUIDO·Filed 2010·Granted Jun 25, 2013·2 cites·6 claims
- 0367US12036283B2Long-acting interleukin-15 receptor agonists and related immunotherapeutic compositions and methodsNEKTAR THERAPEUTICS·Filed 2018·Granted Jul 16, 2024·1 cites·28 claims
- 0465US2024424115A1Long-acting interleukin-15 receptor agonists and related immunotherapeutic compositions and methodsNEKTAR THERAPEUTICS·Filed 2024·Application pending·0 cites
- 0557US9376483B2Universal fibronectin type III binding-domain librariesCAPPUCCILLI GUIDO·Filed 2013·Granted Jun 28, 2016·0 cites·6 claims
- 0653US2009176654A1Universal fibronectin type III binding-domain librariesPROTELIX INC·Filed 2008·Application pending·0 cites
- 0751US2014206576A1Universal fibronectin type iii binding-domain librariesPROTELICA INC·Filed 2014·Application pending·0 cites
- 0850US2008226654A1Uses of mammalian cytokine; related reagentsSCHERING CORP·Filed 2006·Application pending·0 cites
- 0946US2017253645A1Universal fibronectin type iii binding-domain librariesPROTELICA INC·Filed 2017·Application pending·0 cites
- 1045US2023158164A1Method for enhancing cellular immunotherapyNEKTAR THERAPEUTICS·Filed 2020·Application pending·0 cites
- 1145US2009274695A1Inhibition of urokinase-type plasminogen activator (uPA) activityBAZAN J FERNANDO·Filed 2008·Application pending·0 cites
- 1244US8697608B2Universal fibronectin type III binding-domain librariesCAPPUCCILLI GUIDO·Filed 2010·Granted Apr 15, 2014·0 cites·7 claims
- 1344US2003082184A1Uses of mammalian cytokine; related reagentsFiled 2002·Application pending·0 cites
- 1442US2021205413A1SELECTIVE TREG STIMULATOR RUR20kD-IL-2 AND RELATED COMPOSITIONSNEKTAR THERAPEUTICS·Filed 2019·Application pending·0 cites
- 1537US12233104B2Combination of an IL-2RBETA-selective agonist and a long-acting IL-15 agonistNEKTAR THERAPEUTICS·Filed 2016·Granted Feb 25, 2025·0 cites·14 claims
- 1637US2025243275A1Multi-domain binding moleculesIMMUNOCORE LTD·Filed 2025·Application pending·0 cites
- 1735US2019290733A1Conjugates of an il-7 moiety and a polymerNEKTAR THERAPEUTICS·Filed 2016·Application pending·0 cites
- 1833US2017035898A1Conjugates of an il-15 moiety and a polymerNEKTAR THERAPEUTICS·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peter B. Kirk files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →